The diagnosis of this dyslipidemia is suggested by a fluctuating lipid profile, apolipoprotein B (apo B) levels >90th population percentile for age and gender and a first-degree family history of premature cardiovascular disease [15–17]. This evidence concerns the gene APOB and metabolic syndrome.